Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Hearticellgram-AMI
BIOLOGICAL
2 trials
Sponsors
Pharmicell Co., Ltd.
Conditions
Acute Myocardial Infarction
Phase 3
To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.
Completed
NCT01652209
Pharmicell Co., Ltd.
Acute Myocardial Infarction
Start: 2013-09-01
End: 2024-08-12
Updated: 2026-02-09
Unknown Phase
Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration
Recruiting
NCT07400458
Pharmicell Co., Ltd.
Acute Myocardial Infarction
Start: 2022-03-03
End: 2032-09-30
Target: 100
Updated: 2026-02-10